Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This indicates a minor build update to the page rather than any substantive changes to its content.SummaryDifference0.0%

- Check12 days agoChange DetectedThere are no additions or deletions to summarize for this page based on the provided changes data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s UI release/revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check40 days agoChange DetectedMantua, Italy was added to the list of locations and Mantova, Italy was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded the MeSH term 'Severe myoclonic epilepsy in infancy' to the Additional Relevant MeSH Terms on the study record.SummaryDifference0.1%

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.